Abstract Search

ey0017.13-5 | Advocacy, History and Society | ESPEYB17

13.5. Branding of subjects affected with genetic syndromes of severe short stature in developing countries

J Guevara-Aguirre , C Guevara , A Guevara , AA Gavilanes

To read the full abstract: BMJ Case Rep 2020;13:e231737. doi: 10.1136/bcr-2019-231737 The authors report 2 cases of severe short stature, Laron Syndrome and Cornelia-Delange-like syndrome, followed in Ecuador, a country with limited resources. They highlight the tendency of a society to discuss children with severe short stature with derogatory terms to automatically assume tha...

0 shares

ey0019.9-1 | Cancer treatment and growth hormone therapy: a consensus | ESPEYB19

9.1. Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement

MCS Boguszewski , CL Boguszewski , W Chemaitilly , LE Cohen , J Gebauer , C Higham , AR Hoffman , M Polak , KCJ Yuen , N Alos , Z Antal , M Bidlingmaier , BMK Biller , G Brabant , CSY Choong , S Cianfarani , PE Clayton , R Coutant , AA Cardoso-Demartini , A Fernandez , A Grimberg , K Guðmundsson , J Guevara-Aguirre , KKY Ho , R Horikawa , AM Isidori , JOL Jorgensen , P Kamenicky , N Karavitaki , JJ Kopchick , M Lodish , X Luo , AI McCormack , L Meacham , S Melmed , Moab S Mostoufi , HL Muller , SJCMM Neggers , Oliveira MH Aguiar , K Ozono , PA Pennisi , V Popovic , S Radovick , L Savendahl , P Touraine , HM van Santen , G Johannsson

n.karavitaki@bham.ac.uk Eur J Endocrinol. 2022; 186: P35-P52. PMID: 35319491.Brief Summary: An international panel of experts produced this consensus statement after critical review of the existing evidence on the safety of GH replacement in cancer and intracranial tumour survivors and in patients with increased cancer risk. Current evidence does not support an association betwe...

0 shares

ESPE Yearbook of Paediatric Endocrinology

13.5. Branding of subjects affected with genetic syndromes of severe short stature in developing countries

9.1. Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement

BiosciAbstracts